Healthcare
The healthcare industry, traditionally known for its high regulatory barriers and strong resistance to change among service providers, is considered one of the most challenging industries to enter and penetrate. While most companies continue to focus on penetrating high-value markets, cost-conscious developing nations have also emerged as an exciting opportunity for the future. With about half of the world's population residing in these developing nations, pharmaceutical companies and medical devices players can no longer afford to disregard this segment.
Most global healthcare players are currently adopting a two-pronged strategy for growth and expansion. While marketing and relationship building remain the main focus for developed markets especially in the public sector, understanding of product feature requirements and relevant regulatory legislations act as the main priority for developing nations. Volume, rather than price premiums, will be key to drive profitability in developing nations.
Synovate's full suite of consulting services can support your firm's growth and expansion needs, be it to gain first mover's advantage in developing markets or to increase competitive advantages amidst a mature market.